Order Article Reprints

Gebraad A, Ohlsbom R, Miettinen JJ, Emeh P, Pakarinen T-K, Manninen M, Eskelinen A, Kuismanen K, Slipicevic A, Lehmann F, et al. Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen. Cells. 2022; 11(9):1574. https://doi.org/10.3390/cells11091574

Gebraad, Arjen, Roope Ohlsbom, Juho J. Miettinen, Promise Emeh, Toni-Karri Pakarinen, Mikko Manninen, Antti Eskelinen, Kirsi Kuismanen, Ana Slipicevic, Fredrik Lehmann, and et al. 2022. "Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen" Cells 11, no. 9: 1574. https://doi.org/10.3390/cells11091574

Gebraad, A., Ohlsbom, R., Miettinen, J. J., Emeh, P., Pakarinen, T. -K., Manninen, M., Eskelinen, A., Kuismanen, K., Slipicevic, A., Lehmann, F., Nupponen, N. N., Heckman, C. A., & Miettinen, S. (2022). Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen. Cells, 11(9), 1574. https://doi.org/10.3390/cells11091574